381 related articles for article (PubMed ID: 33639625)
21. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
Vashishtha VM
Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516
[TBL] [Abstract][Full Text] [Related]
22. The BCG Vaccine for COVID-19: First Verdict and Future Directions.
Gonzalez-Perez M; Sanchez-Tarjuelo R; Shor B; Nistal-Villan E; Ochando J
Front Immunol; 2021; 12():632478. PubMed ID: 33763077
[TBL] [Abstract][Full Text] [Related]
23. Bacillus Calmette-Guerin vaccination Policy and Consumption of Ammonium Chloride-Enriched Confectioneries May Be Factors Reducing COVID-19 Death Rates in Europe.
Hidvégi M; Nichelatti M
Isr Med Assoc J; 2020 Aug; 22(8):501-504. PubMed ID: 33236583
[TBL] [Abstract][Full Text] [Related]
24. BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers.
Rivas MN; Ebinger JE; Wu M; Sun N; Braun J; Sobhani K; Van Eyk JE; Cheng S; Arditi M
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33211672
[TBL] [Abstract][Full Text] [Related]
25. Impact of Routine Infant BCG Vaccination on COVID-19.
Kinoshita M; Tanaka M
J Infect; 2020 Oct; 81(4):625-633. PubMed ID: 32795481
[TBL] [Abstract][Full Text] [Related]
26. Avoiding COVID-19 complications with diabetic patients could be achieved by multi-dose Bacillus Calmette-Guérin vaccine: a case study of beta cells regeneration.
Ayoub BM; Ramadan E; Ashoush N; Tadros MM; Hendy MS; Elmazar MM; Mousa SA
Pharmazie; 2020 Aug; 75(8):375-380. PubMed ID: 32758336
[TBL] [Abstract][Full Text] [Related]
27. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
Behr MA; Divangahi M; Schurr E
J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
[TBL] [Abstract][Full Text] [Related]
28. BCG vaccination and the risk of COVID 19: A possible correlation.
Ahmed SM; Nasr MA; Elshenawy SE; Hussein AE; El-Betar AH; Mohamed RH; El-Badri N
Virology; 2022 Jan; 565():73-81. PubMed ID: 34742127
[TBL] [Abstract][Full Text] [Related]
29. Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again?
O'Connor E; Teh J; Kamat AM; Lawrentschuk N
Future Oncol; 2020 Jul; 16(19):1323-1325. PubMed ID: 32406253
[No Abstract] [Full Text] [Related]
30. Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2.
Tarabini RF; Rigo MM; Faustino Fonseca A; Rubin F; Bellé R; Kavraki LE; Ferreto TC; Amaral Antunes D; de Souza APD
Front Immunol; 2021; 12():812176. PubMed ID: 35095907
[TBL] [Abstract][Full Text] [Related]
31. BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design.
Covián C; Fernández-Fierro A; Retamal-Díaz A; Díaz FE; Vasquez AE; Lay MK; Riedel CA; González PA; Bueno SM; Kalergis AM
Front Immunol; 2019; 10():2806. PubMed ID: 31849980
[TBL] [Abstract][Full Text] [Related]
32. Is the BCG vaccine a useful tool against COVID-19?
Zhelezova G; Mateeva V; Mateev G
Clin Dermatol; 2021; 39(1):98-103. PubMed ID: 33972060
[TBL] [Abstract][Full Text] [Related]
33. Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave.
Hupert N; Marín-Hernández D; Gao B; Águas R; Nixon DF
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35012976
[TBL] [Abstract][Full Text] [Related]
34. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine.
Nuovo G; Tili E; Suster D; Matys E; Hupp L; Magro C
Ann Diagn Pathol; 2020 Oct; 48():151600. PubMed ID: 32805515
[TBL] [Abstract][Full Text] [Related]
35. Heterologous Boost Following
Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
Front Immunol; 2018; 9():2439. PubMed ID: 30425711
[TBL] [Abstract][Full Text] [Related]
36. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
Mollenkopf HJ; Kursar M; Kaufmann SH
J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
[TBL] [Abstract][Full Text] [Related]
37. Is BCG vaccination causally related to reduced COVID-19 mortality?
Miyasaka M
EMBO Mol Med; 2020 Jun; 12(6):e12661. PubMed ID: 32379923
[TBL] [Abstract][Full Text] [Related]
38. Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: a Retrospective Cohort Study.
Moorlag SJCFM; van Deuren RC; van Werkhoven CH; Jaeger M; Debisarun P; Taks E; Mourits VP; Koeken VACM; de Bree LCJ; Ten Doesschate T; Cleophas MC; Smeekens S; Oosting M; van de Veerdonk FL; Joosten LAB; Ten Oever J; van der Meer JWM; Curtis N; Aaby P; Stabell-Benn C; Giamarellos-Bourboulis EJ; Bonten M; van Crevel R; Netea MG
Cell Rep Med; 2020 Aug; 1(5):100073. PubMed ID: 32838341
[TBL] [Abstract][Full Text] [Related]
39. Bacillus Calmette-Guérin vaccine complications in Iranian children at a University Hospital.
Bolursaz MR; Lotfian F; Velayati AA
Allergol Immunopathol (Madr); 2017; 45(4):356-361. PubMed ID: 28161281
[TBL] [Abstract][Full Text] [Related]
40. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
